OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S. OMLYCLO® (omalizumab-igec) is the first and onlyFDA-approved omalizumab biosimilar approved for all four… CISION PRNewswireOctober 5, 2026
Press ReleaseBitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.02 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $17.4 Billion Bitmine owns 4.9% of the total ETH coin supply of 122.1 million… CISION PRNewswireOctober 5, 2026
Press ReleaseMICROIP and AQLS Draw Defense, Healthcare and Energy Demand for NDAA-Compliant AI Drones at Taiwan Expo USA DALLAS, Oct. 5, 2026 /PRNewswire/ — MICROIP Inc. (TPEx: 7796) and its… CISION PRNewswireOctober 5, 2026
Habitat for Humanity's new global research report finds three in four people are cutting back on essentials to afford housing ATLANTA, Oct. 5, 2026 /PRNewswire/ — Housing costs are forcing millions of… CISION PRNewswireOctober 5, 2026
Press ReleaseManulife Announces Presenting Partnership of The Hinton Lectures™ on AI Safety C$ unless otherwise stated … CISION PRNewswireOctober 5, 2026
ECARX Completes Acquisition of Flyme Software Business, Securing End-to-End Operating System Capabilities Completion brings Flyme Auto and Flyme OS fully in-house, aligning ECARX’s hardware… CISION PRNewswireOctober 5, 2026
Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand, Showcasing its Strength in Specialization Reflects the depth of expertise and innovation Aji Bio-Pharma brings to customers… CISION PRNewswireOctober 5, 2026
Quantinuum and The University of Western Australia Partner to Advance Australia's Quantum Capability Quantinuum and The University of Western Australia (UWA) sign MOU to help… CISION PRNewswireOctober 5, 2026
